跳转至内容
Merck
CN

HADK1MAG-61K

MILLIPLEX® Human Adipokine Panel

Configurable Human Adipokine 5-Plex Panel 1

别名:

adipocyte biomarker listing, adipokine assay snapshot, adipokine biomarker profile, adipokine detection kit, adipokine multiplex product sheet, adipose tissue biomarker details, human adipokine assay overview, human adipokine panel summary, human adipokine product info, human adipokine research tool

登录 查看组织和合同定价。

关于此项目

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000


产品名称

MILLIPLEX® Human Adipokine Panel, Configurable Human Adipokine 5-Plex Panel 1

Quality Level

description

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

inter-assay cv: <10%
intra-assay cv: <10%
(Adipsin), inter-assay cv: <10%
intra-assay cv: <15%
(Adiponectin), inter-assay cv: <10%
intra-assay cv: <15%
(Lipocalin-2/NGAL), inter-assay cv: <10%
intra-assay cv: <20%
(PAI-1 (total)), inter-assay cv: <10%
intra-assay cv: <20%
(Resistin), accuracy: 87%
(Resistin), accuracy: 89%
(Adiponectin), sensitivity: 10 pg/mL
(MinDC+2SD; Adipsin), sensitivity: 21 pg/mL
(MinDC+2SD; Adiponectin), sensitivity: 3.5 pg/mL
(MinDC+2SD; Lipocalin-2/NGAL), sensitivity: 4.4 pg/mL
(MinDC+2SD; Resistin), sensitivity: 5.8 pg/mL
(MinDC+2SD; PAI-1), standard curve range: 13-200,000 pg/mL
(Adipsin), standard curve range: 26-400,000 pg/mL
(Adiponectin), standard curve range: 3.2-50,000 pg/mL
(Lipocalin-2/NGAL), standard curve range: 6.4-100,000 pg/mL
(Resistin), standard curve range: 9.6-150,000 pg/mL
(PAI-1 (total))

technique(s)

multiplexing: suitable

input

serum plasma

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Adipokines are bioactive proteins secreted by adipose tissue that play key roles in metabolic regulation, inflammation, and energy homeostasis. This set of biomarkers—Adiponectin, Adipsin (Factor D), NGAL/Lipocalin-2, PAI-1 (total), and Resistin—provides valuable insights into adipocyte function and systemic metabolic health. These analytes are associated with insulin sensitivity, lipid metabolism, immune response, and cardiovascular risk, making them highly relevant for research in obesity, diabetes, and related metabolic disorders.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 5 analytes in human serum or plasma samples.

Analytes included: Adiponectin, Adipsin/Factor D, NGAL/Lipocalin-2, PAI-1 (total), Resistin

Assay Characteristics: Refer to assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Features:
  • Targets key adipokines involved in metabolic regulation and inflammation
  • Includes 5 analytes relevant to insulin sensitivity, lipid metabolism, and immune signaling
  • Multiplex format enables simultaneous detection from minimal sample volume
  • Compatible with human serum and plasma samples
  • Designed for research in obesity, diabetes, cardiovascular disease, and metabolic syndrome


Benefits:
  • Provides a focused profile of adipocyte-derived biomarkers
  • Supports investigation of metabolic and inflammatory pathways in human models
  • Facilitates evaluation of therapeutic interventions targeting adipose tissue function
  • Enables high-throughput analysis with reduced sample and reagent use
  • Delivers reproducible, sensitive results for translational and clinical research

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under


pictograms

Skull and crossbonesEnvironment

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

法规信息

新产品

此项目有



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

Multiplex immunoassays, such as MILLIPLEX® multiplex metabolic assays, are critical in metabolic syndrome research because they provide a full picture of the different conditions related to it, like diabetes and obesity, as well as save time and sample volume.

查看所有相关内容

Michel T Corban et al.
Journal of the American Heart Association, 7(15), e009881-e009881 (2018-10-30)
Background Soluble urokinase plasminogen activator receptor (su PAR ) is a proinflammatory biomarker associated with immune activation and fibrinolysis inhibition. Plasminogen activator inhibitor ( PAI -1) is associated with excessive fibrin accumulation, thrombus formation, and atherosclerosis. The relationship between cross-coronary
Wellington S Silva Júnior et al.
Journal of diabetes research, 2019, 5238013-5238013 (2019-03-20)
The enzyme dipeptidyl peptidase 4 (DPP4) has been recently recognized as an adipo-myokine. However, studies that associate its constitutive activity with body composition, anthropometry, and insulin resistance (IR) are very scarce and included only healthy people. First, we investigated the
Vinicius J B Martins et al.
The British journal of nutrition, 112(6), 937-944 (2014-07-30)
Undernutrition in early life has been reported to be closely associated with the development of non-communicable diseases in adulthood. Adequate treatment is important for reversing these effects. In the present study, we investigated the effects of undernutrition and anthropometric recovery